About ABBV Dividend Returns
AbbVie Inc. (ABBV) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of ABBV over the past year?
AbbVie Inc. (ABBV) delivered a total return of 14.18% over the past year when dividends are reinvested. The price-only return was 11.00%, meaning dividends contributed an additional 3.18 percentage points to total returns.
Q2How much would $10,000 invested in ABBV be worth today?
A $10,000 investment in AbbVie Inc. one year ago would be worth $11,418 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $11,100. Dividend reinvestment added $318 to the portfolio value.
Q3Does ABBV pay dividends?
Yes, AbbVie Inc. (ABBV) pays dividends. In the last year, ABBV paid approximately $6.22 per share in dividends (2.68% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.
Q4Did ABBV beat the S&P 500?
No, AbbVie Inc. (ABBV) underperformed the S&P 500 by 1.27 percentage points over the past year. ABBV delivered a total return of 14.18%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed ABBV by 1.27pp during this period.
Q5What is ABBV's worst drawdown?
AbbVie Inc. (ABBV) experienced a maximum drawdown of -21.46% over the past year, declining from its peak on 2025-03-10 to its trough on 2025-04-21. The stock recovered to its prior peak by 2025-09-11. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is ABBV's long-term total return over 10, 20, or 30 years?
AbbVie Inc. (ABBV) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 413.0% (17.8% CAGR) — $10,000 would have grown to $51,298. Over 20 years: 717.1% total return (11.1% CAGR) — $10,000 → $81,712. Over 30 years: 717.1% total return (7.3% CAGR) — $10,000 → $81,712. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was ABBV's best and worst year?
AbbVie Inc.'s best calendar year was 2017 with a total return of 59.1%. Its worst year was 2015 with a total return of -7.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 66.8 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).